Intervacc is trading 5.32% down at a live price of €0.06; no specific cause has been established.

  • No company announcement for October 7–9 was found; Intervacc’s announcement listing shows its latest item dated September 15.
  • Biotech weakness is supporting context, but available evidence does not establish that sector or global conditions directly explain this move.